Literature DB >> 19383275

Immunoregulation on the ocular surface: 2nd Cullen Symposium.

Stephen C Pflugfelder1, Michael E Stern.   

Abstract

A one-day symposium with 20 invited participants was held to review current knowledge regarding immunoregulation in the ocular surface and cornea. The program consisted of 11 lectures on various aspects of ocular and systemic immunoregulation, followed by a group discussion to formulate regulatory pathways. The ocular surface and its secondary lymphoid tissues contain numerous components of the innate and adaptive immune systems, which modulate the immune response to suppress or prevent excessive damaging immune reactions. These include factors that regulate induction of the immune response (afferent loop), as well as effector cells and soluble factors (efferent loop). The ocular surface is an immunologically active mucosal site that contains numerous mechanisms to regulate the immune response to prevent tissue destruction and vision loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19383275     DOI: 10.1016/s1542-0124(12)70297-5

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  14 in total

1.  sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model.

Authors:  Yi Wei; Seth P Epstein; Shima Fukuoka; Neil P Birmingham; Xiu-Min Li; Penny A Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-01       Impact factor: 4.799

2.  Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.

Authors:  Yi Wei; Neha Gadaria-Rathod; Seth Epstein; Penny Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-23       Impact factor: 4.799

Review 3.  The core mechanism of dry eye disease is inflammation.

Authors:  Yi Wei; Penny A Asbell
Journal:  Eye Contact Lens       Date:  2014-07       Impact factor: 2.018

Review 4.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

5.  Effects of age and dysfunction on human meibomian glands.

Authors:  Chyong Jy Nien; Salina Massei; Gloria Lin; Cameron Nabavi; Jeremiah Tao; Donald J Brown; Jerry R Paugh; James V Jester
Journal:  Arch Ophthalmol       Date:  2011-04

Review 6.  The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation.

Authors:  Daniel R Saban
Journal:  Ocul Surf       Date:  2013-12-31       Impact factor: 5.033

7.  Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.

Authors:  Megan E Cavet; Karen L Harrington; Thomas R Vollmer; Keith W Ward; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2011-02-18       Impact factor: 2.367

Review 8.  Update and clinical utility of alcaftadine ophthalmic solution 0.25% in the treatment of allergic conjunctivitis.

Authors:  DeGaulle I Chigbu; Alissa M Coyne
Journal:  Clin Ophthalmol       Date:  2015-07-08

9.  Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy.

Authors:  Chun-Ting Lai; Wei-Chieng Yao; Szu-Yuan Lin; Hsin-Yu Liu; Huai-Wen Chang; Fung-Rong Hu; Wei-Li Chen
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  In Vivo and Impression Cytology Study on the Effect of Compatible Solutes Eye Drops on the Ocular Surface Epithelial Cell Quality in Dry Eye Patients.

Authors:  Manuela Lanzini; Claudia Curcio; Rossella Annamaria Colabelli-Gisoldi; Alessandra Mastropasqua; Roberta Calienno; Luca Agnifili; Mario Nubile; Leonardo Mastropasqua
Journal:  Mediators Inflamm       Date:  2015-06-29       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.